机构:[1]State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science andTechnology, Macau, SAR, PR China[2]Department of Chemistry, Southern University of Science and Technology, Shenzhen, Guangdong, PR China深圳市康宁医院深圳医学信息中心[3]TianJin NanKai Hospital, TianJin, PR China
the Science and Technology Development
Fund, Macau SAR (File No.: 003/2018/A1).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类|2 区医学
小类|1 区药学
最新[2025]版:
大类|2 区医学
小类|1 区药学
第一作者:
第一作者机构:[1]State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science andTechnology, Macau, SAR, PR China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Xie Ya-Jia,Gao Wei-Na,Wu Qi-Biao,et al.Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway.[J].Pharmacological research.2020,159:104934.doi:10.1016/j.phrs.2020.104934.
APA:
Xie Ya-Jia,Gao Wei-Na,Wu Qi-Biao,Yao Xiao-Jun,Jiang Ze-Bo...&Fan Xing-Xing.(2020).Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway..Pharmacological research,159,
MLA:
Xie Ya-Jia,et al."Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway.".Pharmacological research 159.(2020):104934